Skip to main content
. Author manuscript; available in PMC: 2008 Feb 1.
Published in final edited form as: Am J Physiol Renal Physiol. 2006 Sep 12;292(2):F647–F654. doi: 10.1152/ajprenal.00017.2006

Fig. 1.

Fig. 1

Overall averaged systolic BP (mmHg) for all groups during the course and % glomerulosclerosis at sacrifice at 16-20 weeks and 36-40 weeks in control, partially insulin treated STZ-diabetes, UNX and RK-NX groups (16-20 weeks only); * p < 0.05 maximum compared to the other groups at both 16-20 weeks and 36-40 week time points.